Black Rock Inc. Selecta Biosciences Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 7,253,975 shares of SELB stock, worth $6.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,253,975

Previous 7,517,950 3.51%

Holding current value

$6.09 Million

Previous $5.19 Million 17.47%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.62 - $0.85 $163,664 - $224,378	-263,975 Reduced 3.51%	7,253,975 $6.09 Million
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.35 $152,248 - $306,769	-227,237 Reduced 2.93%	7,517,950 $5.19 Million
Q3 2023 Nov 13, 2023	SELL	$1.02 - $1.23 $138,636 - $167,179	-135,918 Reduced 1.72%	7,745,187 $8.21 Million
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.4 $5.69 Million - $7.66 Million	5,472,992 Added 227.27%	7,881,105 $8.83 Million
Q1 2023 May 12, 2023	SELL	$1.15 - $1.89 $63,410 - $104,214	-55,140 Reduced 2.24%	2,408,113 $3.35 Million

Q4 2022 Feb 13, 2023	BUY	$0.96 - $1.6 $43,065 - $71,776	44,860 Added 1.85%	2,463,253 $2.78 Million
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $58,126 - $113,630	43,704 Added 1.84%	2,418,393 $3.97 Million
Q2 2022 Aug 12, 2022	SELL	$0.67 - $1.4 $2.94 Million - $6.15 Million	-4,390,156 Reduced 64.9%	2,374,689 $3.11 Million
Q1 2022 May 12, 2022	SELL	$1.23 - $3.31 $230,055 - $619,092	-187,037 Reduced 2.69%	6,764,845 $8.32 Million
Q4 2021 Feb 10, 2022	SELL	$2.89 - $4.43 $39,633 - $60,753	-13,714 Reduced 0.2%	6,951,882 $22.7 Million
Q3 2021 Nov 09, 2021	BUY	$3.36 - $4.62 $922,679 - $1.27 Million	274,607 Added 4.1%	6,965,596 $29 Million
Q2 2021 Aug 11, 2021	BUY	$2.82 - $5.01 $18.9 Million - $33.5 Million	6,690,989 New	6,690,989 $28 Million

Others Institutions Holding SELB

# of Institutions

Shares Held

41.4M

Call Options Held

16.8K

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account